Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Amidonal
2. Aprindine
3. Fiboran
1. Aprindine Hcl
2. 33237-74-0
3. Aspenon
4. Fibocil
5. Compound 83846
6. Aprinidine Chloride
7. Amidonal
8. Aprindinehcl
9. Aprindine (hydrochloride)
10. Pb5ekt7q2v
11. N-(2,3-dihydro-1h-inden-2-yl)-n',n'-diethyl-n-phenyl-1,3-propanediamine Hydrochloride
12. Nsc-284614
13. Fiboran
14. Ritmusin
15. 33237-74-0 (hcl)
16. Dsstox_cid_26726
17. Dsstox_rid_81856
18. Dsstox_gsid_46726
19. Lilly 83846
20. N'-(2,3-dihydro-1h-inden-2-yl)-n,n-diethyl-n'-phenylpropane-1,3-diamine;hydrochloride
21. Cas-33237-74-0
22. Ccris 5480
23. Ncgc00167576-01
24. Aprindine Hydrochloride [usan:jan]
25. Einecs 251-418-7
26. Unii-pb5ekt7q2v
27. Nsc 284614
28. Ms 5075
29. Ms-5075
30. Aspenon (tn)
31. N-(2,3-dihydro-1h-inden-2-yl)-n',n'-diethyl-n-phenylpropane-1,3-diamine Monohydrochloride
32. 2-indanamine, N-(3-(diethylamino)propyl)-n-phenyl-, Hydrochloride
33. N,n-diethyl-n'-2-indanyl-n'-phenyl-1,3-propanediamine Hydrochloride
34. N,n-diethyl-n'-2-indanyl-n'-phenyl-1,3-propanediamine Monohydrochloride
35. 1,3-propanediamine, N-(2,3-dihydro-1h-inden-2-yl)-n',n'-diethyl-n-phenyl-, Monohydrochloride
36. Compound-83846
37. Mls004712062
38. Schembl122403
39. Chembl2104501
40. Dtxsid5046726
41. Chebi:31229
42. Hy-a0236a
43. Aprindine Hydrochloride [mi]
44. Tox21_112569
45. Tox21_501190
46. Aprindine Hydrochloride [jan]
47. Aprindine Hydrochloride [usan]
48. 1,3-propanediamine, N,n-diethyl-n'-2-indanyl-n'-phenyl-, Monohydrochloride
49. Akos015994694
50. Aprindine Hydrochloride (jp17/usan)
51. Tox21_112569_1
52. Aprindine Hydrochloride [mart.]
53. Ccg-222494
54. Ks-1222
55. Lp01190
56. Aprindine Hydrochloride [who-dd]
57. Ncgc00167576-02
58. Ncgc00261875-01
59. Smr001456520
60. Cs-0133610
61. D01326
62. Aprindine Hydrochloride, >=98% (hplc), Solid
63. J-019105
64. Q27286446
65. N1-(2,3-dihydro-1h-inden-2-yl)-n3,n3-diethyl-n1-phenylpropane-1,3-diamine Hydrochloride
| Molecular Weight | 358.9 g/mol |
|---|---|
| Molecular Formula | C22H31ClN2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 8 |
| Exact Mass | 358.2175767 g/mol |
| Monoisotopic Mass | 358.2175767 g/mol |
| Topological Polar Surface Area | 6.5 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 332 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Voltage-Gated Sodium Channel Blockers
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Aprindine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aprindine Hydrochloride, including repackagers and relabelers. The FDA regulates Aprindine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aprindine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aprindine Hydrochloride supplier is an individual or a company that provides Aprindine Hydrochloride active pharmaceutical ingredient (API) or Aprindine Hydrochloride finished formulations upon request. The Aprindine Hydrochloride suppliers may include Aprindine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Aprindine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Aprindine Hydrochloride Drug Master File in Japan (Aprindine Hydrochloride JDMF) empowers Aprindine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Aprindine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Aprindine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Aprindine Hydrochloride suppliers with JDMF on PharmaCompass.
A Aprindine Hydrochloride written confirmation (Aprindine Hydrochloride WC) is an official document issued by a regulatory agency to a Aprindine Hydrochloride manufacturer, verifying that the manufacturing facility of a Aprindine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Aprindine Hydrochloride APIs or Aprindine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Aprindine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Aprindine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
Aprindine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aprindine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aprindine Hydrochloride GMP manufacturer or Aprindine Hydrochloride GMP API supplier for your needs.
A Aprindine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Aprindine Hydrochloride's compliance with Aprindine Hydrochloride specifications and serves as a tool for batch-level quality control.
Aprindine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Aprindine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aprindine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Aprindine Hydrochloride EP), Aprindine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aprindine Hydrochloride USP).
LOOKING FOR A SUPPLIER?
